Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 121 results found. Search for [ favipiravir coronavirus ]

Results 1 to 21 of 121
BusinessToday.In
May 4, 2021
Bajaj Healthcare Limited (BHL) has received approval from India's drug regulator, to manufacture and market 'Favijaj' in India for the treatment of COVID-19 from May 4, 2021, onwards


BusinessToday.In
New Delhi, May 3, 2021
A total of 122 crore doses of COVID-19 vaccines would be required to vaccinate the population of 59 crore in 18-45 years age group, the Centre has said; According to the preliminary data of state-owned fuel retailers, the second wave of coronavirus sweeping the nation has pummelled fuel sales in April as local restrictions clamped to curb the spread of infection stifled demand; The Centre may ask medical students, including final-year students of MBBS, to help India battle coronavirus crisis, as per government sources, amid a shortage of healthcare personnel as India battles the second wave of Covid-19. Watch this and more on News Blast.Also Read: 'Vaccine shortage may continue till July,' says Serum CEO Adar Poonawalla


Rashi Bisaria
New Delhi, May 3, 2021
India's fuel sales drop in April on local restrictions to curb second wave of COVID-19 According to the preliminary data of state-owned fuel retailers, the second wave of coronavirus sweeping the nation has pummelled fuel sales in April as local restrictions clamped to curb the spread of infection stifled demand. At the end of April, overall fuel demand is down by about 7 per cent from pre-Covid level of April 2019. COVID-19 vaccination: Centre says 122 cr doses needed to inoculate 59 cr ...


BusinessToday.In
November 23, 2020
The study found that patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.


BusinessToday.In
November 7, 2020
Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


Reuters
October 16, 2020
The company said last month a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month


Aseem Thapliyal
October 14, 2020
Jhunjhunwala increased stake in the company to 1.53 percent in Q2 from 1.47 percent in June quarter


PB Jayakumar
October 14, 2020
The indicated price is for treatment using the drug for about a month, or a treatment cycle depending on the disease progression and patient condition


BusinessToday.In
New Delhi, October 8, 2020
Tata Consultancy Services has announced a salary hike for its employees effective October 1; The World Bank has warned that by 2021, as many as 150 million people are likely to be in extreme poverty because of the coronavirus pandemic; Chinese gaming app PUBG Mobile is reportedly talking to telecom major Bharti Airtel to bring the popular multiplayer game back on the mobile screens of its Indian fans. Watch this and more on News Blast.Also Read: Hetero plans to make COVID-19 drug Favipiravir in injection form


BusinessToday.In
October 8, 2020
Last month, Hetero became the first Indian drug company to launch Favipiravir in 800/200mg dosage for the treatment of mild-to-moderate symptomatic Covid-19 patients


BusinessToday.In
September 22, 2020
With the 800 mg of Favipiravir tablet, COVID-19 patients could undergo a more relaxed dosage, which will increase their compliance and experience


PB Jayakumar
September 21, 2020
The tech-driven platform that offers Continuous Medical Education (CME) and Continuing Professional Development (CPD) programmes for healthcare professionals, trained over 100,000 healthcare professionals over the last 6 months


BusinessToday.In
September 9, 2020
DCGI has approved Remdesivir for \"restricted emergency use\" in India for treatment of COVID-19 patients hospitalised with severe symptoms


BusinessToday.In
August 26, 2020
India Stock Market Highlights: Bajaj Auto, followed by Bajaj Finserv, IndusInd Bank, M&M, PowerGrid, Bajaj Finance, Axis Bank, Kotak Bank and ICICI Bank were among the top gainers today. On the other hand, Bharti Airtel, Asian Paints, HCL Tech, HDFC and TCS were among the laggards


Associated Press
August 21, 2020
In an online report Thursday, Pfizer researchers compared data from early-stage testing of two vaccine candidates. Both revved immune systems similarly, and neither caused severe side effects


Mansi Jaswal
August 20, 2020
A survey conducted by Max Bupa Health Insurance company found that millennials - people in the age group of 25 to 35 years - were increasingly curious to understand health coverage


BusinessToday.In
August 20, 2020
Along with the free home delivery service, Dr Reddy's also launched a helpline centre operational between 9 am to 9 pm IST, Monday through Saturday


BusinessToday.In
August 19, 2020
Dr Reddy's Avigan will come in a complete therapy pack of 122 tablets with a two-year shelf life


BusinessToday.In
August 17, 2020
India Stock Market News Updates Today: NTPC, Tata Steel, L&T, Titan and Kotak Bank were among the major gainers on Sensex pack. While, RIL, SBI, HDFC, HDFC Bank, Axis Bank and ICICI Bank were among the top laggards.


PAGES 1 OF 7  12345